Nanfang Hospital, Southern Medical University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
10 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 6 with minor changes only.
- Notable: AI Models in Clinical Pathology Diagnosis: A Multicenter RCT Recruitment opened
- Minor: PASS · Impact of Perioperative Antibiotic Use on Surgical Scarring Completed without a posted recruiting period
-
Minor: 4 trials marked Unknown by the registry's verification sweep Changed
- Minor: Bispecific Antibody MR001 · Advanced Solid Tumors Changed Registry marked status Unknown (sponsor has not verified the record since Nov 2023); last known: Not Yet Recruiting
- Minor: Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Recruiting
- Minor: Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy Changed Registry marked status Unknown (sponsor has not verified the record since May 2023); last known: Recruiting
- Notable: Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes · Acute Anterior Circulation Thrombectomy Recruitment opened
- Notable: Turmeric-Derived Nanoparticle Hydrogel · Diabetic Foot Ulcer Wounds Start date pushed from Sep 1, 2026 to Nov 10, 2026
- Minor: Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios Trial completed
- Notable: Impact of Computer-aided Detection System on the Right Colon Adenoma Miss Rate Primary endpoint(s) modified
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-06 | NCT07921732 Prospective, Multicenter, Randomized Controlled Phase III Trial of Biological Mesh for… | Recruiting | |
| 2026-10-29 | NCT07903454 Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients | Recruiting | |
| 2026-10-21 | NCT07885228 Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease | Phase 1/2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 2 | |
| Phase 1 | 1 | |
| Phase 1/2 | 3 | |
| Phase 2 | 21 | |
| Phase 2/3 | 6 | |
| Phase 3 | 3 | |
| Phase 4 | 9 |
Not charted: 118 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 31
Head & Neck Cancer (13) · Liver Cancer (13) · Gastric Cancer (12) · Stroke (11) · Leukemia (9) · Esophageal Cancer (6) · Lung Cancer (6) · Colorectal Cancer (5) · Acute Myeloid Leukemia (AML) (4) · Diabetes (4)
Get alerts when Nanfang Hospital, Southern Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.